Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 3,142.20
-65.90 (-2.05%)
Nov 21, 2025, 3:30 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 262.53 billion as of November 21, 2025. Its market cap has increased by 2.05% in one year.
Market Cap
262.53B
Enterprise Value
252.81B
Revenue
25.29B
Ranking
n/a
PE Ratio
51.10
Stock Price
3,142.20
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 262.53B, an increase of 285.05%. That is a compound annual growth rate of 14.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 262.53B | 5.01% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | 190.13B | 54.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.27T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.06T |
| Zydus Lifesciences | 930.06B |
| Mankind Pharma | 925.45B |
| Aurobindo Pharma | 700.39B |
| Fortis Healthcare | 695.32B |